SPAC Business Combination Beta

Note: Premium members can sort this table by Symbol, Business Combination Date, Expected Closing Date, SPAC Symbol, Deal Completion Date and Deal Status.

  Symbol Company Business
Combination Date
Expected
Closing Date
SPAC Name SPAC Symbol IPO Date Deal
Completion Date
Deal
Status
VIEW View, Inc. 11/30/2020 Q1 2021 CF Finance Acquisition II VIEW 08/27/2020 03/08/2021 Completed

Business Combination details

Unit Symbol: CFIIU, Unit Price: $9.81

Warrant Symbol: VIEWW, Warrant Price: $1.65

August 07, 2020: Registration

August 27, 2020: Initial Public Offering

August 28, 2020: Prospectus

November 30, 2020: Business Combination

Update(s)

August 27, 2020 – CF Finance Acquisition Corp. II (CFII) announced today that it priced its initial public offering of 50,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the symbol “CFIIU” beginning today. Each unit consists of one share of Class A common stock and one-third of one warrant. Each whole warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on the NASDAQ under the symbols “CFII” and “CFIIW,” respectively.

November 30, 2020- View, Inc., a Silicon Valley-based smart window company, and CF Finance Acquisition Corp. II (CFII), a special purpose acquisition company sponsored by Cantor Fitzgerald, announced they have entered into a definitive merger agreement. The combined company will be called View, Inc. and will be publicly listed on the NASDAQ market following the close of the transaction.

January 11, 2011: CF Finance Acquisition Corp. II (CFII) and View, Inc. announced GIC, Singapore’s sovereign wealth fund, has agreed to invest an additional $200 million in the previously announced private investment in public equity (“PIPE”) issuance. The additional investment from GIC increases the fully committed PIPE investment from $300 million to $500 million.

February 17, 2021: CF Finance Acquisition Corp. II (CFII) announced that the Securities and Exchange Commission has declared effective its registration statement on Form S-4 in connection with its previously announced business combination with View, Inc. CF II will hold a Special Meeting of Stockholders at 10:00 a.m. Eastern time on March 5, 2021 to approve, among other things, the previously announced business combination with View. The transaction, which has been unanimously approved by the boards of directors of both CF II and View, is expected to close in the first quarter of 2021, subject to regulatory and stockholder approvals, and other customary closing conditions.

March 8, 2021: View, Inc. announced that it has completed its business combination with CF Finance Acquisition Corp. II (CFII). The Business Combination was approved by CF II stockholders in a special meeting held on March 5, 2021. Beginning on March 9, 2021, View shares will trade on the Nasdaq Stock Market under the ticker symbol “VIEW” and its warrants will trade on the Nasdaq Stock Market under the ticker symbol “VIEWW”.

MILE Metromile 11/24/2020 Q1 2021 INSU Acquisition II MILE 09/03/2020 02/09/2021 Completed

Business Combination details

Unit Symbol: INAQU, Unit Price: $20.45

Warrant Symbol: INAQW, Warrant Price: $5.67

July 30, 2020: Registration

September 03, 2020: Initial Public Offering

September 04, 2020: Prospectus

November 24, 2020: Business Combination

Update(s)

September 2, 2020: INSU Acquisition Corp. II (INAQ), a blank-check company formed for the purpose of acquiring or merging with one or more businesses or entities in the insurance industry, today announced the pricing of its upsized initial public offering of 20,000,000 units at a price of $10.00 per unit, for gross proceeds to the Company of $200,000,000. The Company’s units will be listed on the Nasdaq Capital Market under the symbol “INAQU” and will begin trading on September 3, 2020. Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-third of one warrant, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “INAQ” and “INAQW,” respectively. 

November 24, 2020: Metromile, Inc., the leading digital insurance platform and pay-per-mile auto insurer, and INSU Acquisition Corp. II (INAQ), a publicly-traded special purpose acquisition company sponsored by Cohen & Company, LLC, a subsidiary of Cohen & Company Inc. (COHN), announced that they have entered into a definitive business combination that will result in Metromile becoming a publicly listed company. Upon closing of the transaction, the combined company will be named Metromile, Inc. and is expected to remain listed on NASDAQ under the new ticker symbol “MLE”.

February 9, 2021: Metromile (MILE) consummated the previously announced merger by and among INSU II Merger Sub Corp.

BFLY Butterfly Network 11/20/2020 Q1 2021 Longview Acquisition BFLY 05/21/2020 02/16/2021 Completed

Business Combination details

Unit Symbol: LGVW-UN, Unit Price: $26.06

Warrant Symbol: BFLY-WT, Warrant Price: $6.09

May 01, 2020: Registration

May 21, 2020: Initial Public Offering

May 22, 2020: Prospectus

November 20, 2020: Business Combination

Update(s)

On May 20, 2020, the Registration Statement on Form S-1 relating to the initial public offering  of Longview Acquisition Corp. was declared effective by the U.S. Securities and Exchange Commission. On May 26, 2020, the Company consummated the IPO of 36,000,000 units.

November 20, 2020: Butterfly Network, an innovative digital health company that is working to enable universal access to superior medical imaging, and Longview Acquisition Corp. (LGVW), a special purpose acquisition company sponsored by Glenview Capital Management, LLC, announced that they have entered into a definitive business combination agreement. Upon closing, the combined company’s Class A common stock is expected to be traded on the New York Stock Exchange under the symbol “BFLY.”

February 12, 2021: Longview Acquisition (LGVW) announced that its stockholders voted to approve the proposed business combination with Butterfly Network, Inc.

February 16, 2021: Butterfly Network (BFLY) announced that it has completed its business combination with Longview Acquisition (LGVW).

LOTZ CarLotz, Inc. 10/22/2020 Q4 2020 Acamar Partners Acquisition Corp. LOTZ 02/22/2019 01/21/2021 Completed

Business Combination details

Warrant Symbol: LOTZW, Warrant Price: $2.20

January 08, 2019: Registration

February 22, 2019: Initial Public Offering

February 22, 2019: Prospectus

October 22, 2020: Business Combination

Update(s)

February 22, 2019: Acamar Partners Acquisition priced its initial public offering of 30,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market and trade under the ticker symbol “ACAMU” beginning February 22, 2019. Each unit consists of one share of the Company’s Class A common stock and one-third of one redeemable warrant, each whole warrant enabling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “ACAM” and “ACAMW,” respectively.

October 22, 2020: Acamar Partners Acquisition (ACAM) and CarLotz, Inc., one of the largest privately-held used vehicle retail disruptors with the industry’s only consignment-to-retail sales platform, announced today they executed a definitive business combination agreement that would make CarLotz a public company. At closing, anticipated in the fourth quarter of 2020, the combined company will be named CarLotz, Inc. and is expected to remain listed on Nasdaq and trade under the new ticker symbol LOTZ.

January 21, 2021: CarLotz (LOTZ) announced that it has completed its business combination with Acamar Partners Acquisition (ACAM). The Business Combination was approved on January 20, 2021 by Acamar Partners’ stockholders. Beginning January 22, 2021, CarLotz’ shares will trade on the Nasdaq Global Market under the ticker symbol “LOTZ.”

GMTX GeminiTherapeutics 10/15/2020 January 2021 FS Development GMTX 08/12/2020 02/08/2021 Completed

Business Combination details

July 24, 2020: Registration

August 12, 2020: Initial Public Offering

August 13, 2020: Prospectus

October 15, 2020: Business Combination

Update(s)

August 12, 2020 – FS Development Corp. (FSDC) announced today that it priced its initial public offering of 10,500,000 shares of Class A common stock at $10.00 per share. The shares will be listed on The Nasdaq Capital Market and trade under the ticker symbol “FSDC” beginning August 12, 2020. The Company expects the offering to be consummated on August 14, 2020.

October 15, 2020: Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), and FS Development Corp. (FSDC) announced they have entered into a definitive merger agreement. Upon closing of the transaction, the company will be renamed “Gemini Therapeutics, Inc.” and will be led by Jason Meyenburg, Chief Executive Officer of Gemini. The Combined Company’s common stock is expected to be listed on Nasdaq.

February 3, 2021: Shareholders of FS Development (FSDC) approved its combination with biotech firm Gemini Therapeutics.

February 8, 2021: Gemini Therapeutics announced the completion of its business combination with FS Development (FSDC). Gemini Therapeutics, Inc., the resulting combined company, will commence trading its shares today on the Nasdaq Global Market under the symbol “GMTX.”

ETWO E2open 10/14/2020 Q1 2021 CC Neuberger Principal Holdings I ETWO 04/24/2020 02/05/2021 Completed

Business Combination details

Unit Symbol: PCPL-UN, Unit Price: $11.63

Warrant Symbol: PCPL-WT, Warrant Price: $2.48

March 06, 2020: Registration

April 24, 2020: Initial Public Offering

April 27, 2020: Prospectus

October 14, 2020: Business Combination

Update(s)

April 24, 2020: The Registration Statement on Form S-1 relating to the initial public offering of CC Neuberger Principal Holdings I was declared effective by the U.S. Securities and Exchange Commission.

October 14, 2020: E2open, a leading network-based provider of 100% cloud-based, end-to-end supply chain management software, today announced it has entered into a business combination agreement with CC Neuberger Principal Holdings I (PCPL), a publicly traded special purpose acquisition company. Upon closing of the transaction, E2open will become a publicly traded company, and it is expected that its common stock will be listed on the New York Stock Exchange under the symbol “ETWO”. Michael Farlekas, who has served as CEO of the Company since 2015, will continue to lead the business post-transaction.

February 2, 2021: CC Neuberger Principal Holdings I (PCPL) announced that its shareholders approved its combination with supply chain software provider E2Open.

February 5, 2021: E2open and CC Neuberger Principal Holdings I (PCPL) announced that they have completed their business combination. The common stock of the combined company will trade under the symbol "ETWO" on the New York Stock Exchange, beginning February 5, 2021. 

CLOV Clover Health Investments, Corp. 10/06/2020 Q4 2020 Social Capital Hedosophia III CLOV 04/22/2020 01/07/2021 Completed

Business Combination details

Warrant Symbol: CLOVW, Warrant Price: $1.78

February 28, 2020: Registration

April 22, 2020: Initial Public Offering

April 23, 2020: Prospectus

October 06, 2020: Business Combination

Update(s)

pril 21, 2020: Social Capital Hedosophia Holdings Corp. III priced its initial public offering of 72,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange and trade under the ticker symbol "IPOC.U" beginning April 22, 2020. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the NYSE under the symbols "IPOC" and "IPOC WS," respectively.
October 6, 2020: Clover Health Investments, which operates next-generation Medicare Advantage plans, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Hedosophia Holdings Corp. III.
January 6, 2021: Social Capital Hedosophia Holdings Corp. III, announced that in an extraordinary general meeting on January 6, 2021, its shareholders voted to approve its proposed business combination with Clover Health Investments, Corp. The business combination is expected to close on January 7, 2021. Trading is expected to begin on The Nasdaq Global Select Market on January 8, 2021, under the new ticker symbol “CLOV” for Clover Health Class A common stock and “CLOVW” for Clover Health warrants.
January 7, 2021: Clover Health Investments, an innovative technology company improving health outcomes for America’s seniors, and Social Capital Hedosophia Holdings (IPOC)  completed their previously announced business combination to form one of the nation’s fastest growing publicly-traded Medicare Advantage insurers. The newly formed company is named Clover Health Investments, Corp. and its shares of Class A common stock and warrants will start trading on The Nasdaq Global Select Market under the new ticker symbols “CLOV” and “CLOVW,” respectively.

April 21, 2020: Social Capital Hedosophia Holdings Corp. III priced its initial public offering of 72,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange and trade under the ticker symbol "IPOC.U" beginning April 22, 2020. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the NYSE under the symbols "IPOC" and "IPOC WS," respectively.

October 6, 2020: Clover Health Investments, which operates next-generation Medicare Advantage plans, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Hedosophia Holdings Corp. III.

January 6, 2021: Social Capital Hedosophia Holdings Corp. III, announced that in an extraordinary general meeting on January 6, 2021, its shareholders voted to approve its proposed business combination with Clover Health Investments, Corp. The business combination is expected to close on January 7, 2021. Trading is expected to begin on The Nasdaq Global Select Market on January 8, 2021, under the new ticker symbol “CLOV” for Clover Health Class A common stock and “CLOVW” for Clover Health warrants.

January 7, 2021: Clover Health Investments, an innovative technology company improving health outcomes for America’s seniors, and Social Capital Hedosophia Holdings (IPOC)  completed their previously announced business combination to form one of the nation’s fastest growing publicly-traded Medicare Advantage insurers. The newly formed company is named Clover Health Investments, Corp. and its shares of Class A common stock and warrants will start trading on The Nasdaq Global Select Market under the new ticker symbols “CLOV” and “CLOVW,” respectively.

DNMR Danimer Scientific 10/05/2020 Q4 2020 Live Oak Acquisition DNMR 05/06/2020 12/29/2020 Completed

Business Combination details

Warrant Symbol: DNMR-WT, Warrant Price: $21.04

March 02, 2020: Registration

May 06, 2020: Initial Public Offering

May 06, 2020: Prospectus

October 05, 2020: Business Combination

Update(s)

May 6, 2020: Live Oak Acquisition Corp priced its initial public offering of 20,000,000 units at $10.00 per unit. While the Company may pursue an initial business combination target in any business or industry, it intends to focus its search on companies in the financial services, industrial, business services, and real estate sectors. The units will be listed on the New York Stock Exchange and will begin trading tomorrow, Wednesday, May 6, 2020, under the ticker symbol “LOAK.U” Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on the NYSE under the symbols “LOAK” and “LOAK WS,” respectively.

October 5, 2020: Danimer Scientific, a next generation bioplastics company focused on the development and production of biodegradable materials, and Live Oak Acquisition (LOAK) announced a definitive agreement for a business combination that would result in Danimer Scientific becoming a public company. Upon closing of the transaction, the combined company will be renamed Danimer Scientific and is expected to remain listed on the NYSE under a new ticker symbol. Danimer will continue to be led by Stephen E. Croskrey, Danimer’s current Chief Executive Officer.

December 29, 2020: Meredian Holdings Group doing business as Danimer Scientific, a next generation bioplastics company focused on the development and production of biodegradable materials, and Danimer Scientific announced that they have completed their previously announced business combination. In connection with the closing, Live Oak changed its name to Danimer Scientific. The common stock of Danimer Scientific will trade under the ticker symbol “DNMR” on the New York Stock Exchange beginning December 30, 2020.

PLBY Playboy 10/01/2020 Q1 2021 Mountain Crest Acquisition PLBY 06/05/2020 02/11/2021 Completed

Business Combination details

Unit Symbol: MCACU, Unit Price: $15.95

Warrant Symbol: MCACR, Warrant Price: $1.30

November 10, 2020: Registration

June 05, 2020: Initial Public Offering

June 05, 2020: Prospectus

October 01, 2020: Business Combination

Update(s)

June 4, 2020: Mountain Crest Acquisition Corp priced its initial public offering of 5,000,000 units at $10.00 per unit. The units are expected to be listed on The NASDAQ Capital Market and trade under the ticker symbol "MCACU" beginning tomorrow, June 5, 2020. Each unit consists of one share of common stock and one right to receive one-tenth of one share of common stock upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the common stock and rights are expected to be listed on NASDAQ under the symbols "MCAC," and "MCACR," respectively.

October 1, 2020: Playboy Enterprises, Inc. and Mountain Crest Acquisition Corp. (MCAC) announced the signing of a definitive merger agreement to return Playboy to the public markets. In addition, they announced the signing of definitive purchase agreements with institutional and accredited investors for the purchase of $50 million of common stock at $10 per share. Upon closing of the transaction, Mountain Crest will be renamed and is expected to remain listed on the Nasdaq Stock Market under ticker PLBY.

February 9, 2021: Mountain Crest Acquisition (MCAC) announced that in a special meeting of stockholders, its stockholders voted to approve its proposed business combination with Playboy Enterprises, Inc. The business combination is expected to close on February 10, 2021, subject to the satisfaction of certain customary closing conditions. As part of the consummation of the business combination, Mountain Crest will change its name to “PLBY Group, Inc.” Trading on The Nasdaq Global Market, under the new ticker symbol “PLBY,” is expected to begin on February 11, 2021.Playboy Enterprises, Inc. and Mountain Crest Acquisition Corp. (MCAC) announced the signing of a definitive merger agreement to return Playboy to the public markets. In addition, they announced the signing of definitive purchase agreements with institutional and accredited investors for the purchase of $50 million of common stock at $10 per share. Upon closing of the transaction, Mountain Crest will be renamed and is expected to remain listed on the Nasdaq Stock Market under ticker PLBY.

February 10, 2021: Playboy Enterprises (PLBY) and Mountain Crest Acquisition Corp (MCAC) announced the completion of their business combination.

NUVB Nuvation Bio 10/01/2020 Q1 2021 Panacea Acquisition NUVB 07/01/2020 02/10/2021 Completed

Business Combination details

Unit Symbol: PANA-UN, Unit Price: $11.47

Warrant Symbol: NUVB-WT, Warrant Price: $2.60

June 12, 2020: Registration

July 01, 2020: Initial Public Offering

July 02, 2020: Prospectus

October 01, 2020: Business Combination

Update(s)

June 30, 2020 — Panacea Acquisition Corp. (PANA), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The Company is sponsored by EcoR1 Panacea Holdings, LLC, an affiliate of EcoR1 Capital, LLC. While the Company may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business operating in the biotechnology sector.

October 21, 2020: Nuvation Bio Inc., a biopharmaceutical company focused on revolutionizing cancer treatment by discovering, developing and delivering therapies that tackle some of the greatest needs in oncology, and Panacea Acquisition Corp. (PANA), a special purpose acquisition company (SPAC) sponsored by EcoR1 Capital, today announced they have entered into a definitive business combination agreement. Upon closing of the transaction, Panacea will be renamed Nuvation Bio Inc.; its common stock is expected to remain listed on the New York Stock Exchange under the new ticker symbol "NUVB."

February 9, 2021: Panacea Acquisition Corporation (PANA) announced that its shareholders have approved its combination with drug developer Nuvation Bio at a special meeting.

February 10, 2021: Nuvation Bio and Panacea Acquisition Corporation (PANA) consummated the transactions contemplated by the Agreement and Plan of Merger among them.

Note: Premium members can sort this table by Target, Business Combination Date and SPAC Symbol. Desktop Version

  Target Business
Combination Date
SPAC Symbol
View, Inc. 11/30/2020 VIEW

Business Combination details

Unit Symbol: CFIIU, Unit Price: $9.81

Warrant Symbol: VIEWW, Warrant Price: $1.65

August 07, 2020: Registration

August 27, 2020: Initial Public Offering

August 28, 2020: Prospectus

November 30, 2020: Business Combination

Update(s)

August 27, 2020 – CF Finance Acquisition Corp. II (CFII) announced today that it priced its initial public offering of 50,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the symbol “CFIIU” beginning today. Each unit consists of one share of Class A common stock and one-third of one warrant. Each whole warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on the NASDAQ under the symbols “CFII” and “CFIIW,” respectively.

November 30, 2020- View, Inc., a Silicon Valley-based smart window company, and CF Finance Acquisition Corp. II (CFII), a special purpose acquisition company sponsored by Cantor Fitzgerald, announced they have entered into a definitive merger agreement. The combined company will be called View, Inc. and will be publicly listed on the NASDAQ market following the close of the transaction.

January 11, 2011: CF Finance Acquisition Corp. II (CFII) and View, Inc. announced GIC, Singapore’s sovereign wealth fund, has agreed to invest an additional $200 million in the previously announced private investment in public equity (“PIPE”) issuance. The additional investment from GIC increases the fully committed PIPE investment from $300 million to $500 million.

February 17, 2021: CF Finance Acquisition Corp. II (CFII) announced that the Securities and Exchange Commission has declared effective its registration statement on Form S-4 in connection with its previously announced business combination with View, Inc. CF II will hold a Special Meeting of Stockholders at 10:00 a.m. Eastern time on March 5, 2021 to approve, among other things, the previously announced business combination with View. The transaction, which has been unanimously approved by the boards of directors of both CF II and View, is expected to close in the first quarter of 2021, subject to regulatory and stockholder approvals, and other customary closing conditions.

March 8, 2021: View, Inc. announced that it has completed its business combination with CF Finance Acquisition Corp. II (CFII). The Business Combination was approved by CF II stockholders in a special meeting held on March 5, 2021. Beginning on March 9, 2021, View shares will trade on the Nasdaq Stock Market under the ticker symbol “VIEW” and its warrants will trade on the Nasdaq Stock Market under the ticker symbol “VIEWW”.

Metromile 11/24/2020 MILE

Business Combination details

Unit Symbol: INAQU, Unit Price: $20.45

Warrant Symbol: INAQW, Warrant Price: $5.67

July 30, 2020: Registration

September 03, 2020: Initial Public Offering

September 04, 2020: Prospectus

November 24, 2020: Business Combination

Update(s)

September 2, 2020: INSU Acquisition Corp. II (INAQ), a blank-check company formed for the purpose of acquiring or merging with one or more businesses or entities in the insurance industry, today announced the pricing of its upsized initial public offering of 20,000,000 units at a price of $10.00 per unit, for gross proceeds to the Company of $200,000,000. The Company’s units will be listed on the Nasdaq Capital Market under the symbol “INAQU” and will begin trading on September 3, 2020. Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-third of one warrant, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “INAQ” and “INAQW,” respectively. 

November 24, 2020: Metromile, Inc., the leading digital insurance platform and pay-per-mile auto insurer, and INSU Acquisition Corp. II (INAQ), a publicly-traded special purpose acquisition company sponsored by Cohen & Company, LLC, a subsidiary of Cohen & Company Inc. (COHN), announced that they have entered into a definitive business combination that will result in Metromile becoming a publicly listed company. Upon closing of the transaction, the combined company will be named Metromile, Inc. and is expected to remain listed on NASDAQ under the new ticker symbol “MLE”.

February 9, 2021: Metromile (MILE) consummated the previously announced merger by and among INSU II Merger Sub Corp.

Butterfly Network 11/20/2020 BFLY

Business Combination details

Unit Symbol: LGVW-UN, Unit Price: $26.06

Warrant Symbol: BFLY-WT, Warrant Price: $6.09

May 01, 2020: Registration

May 21, 2020: Initial Public Offering

May 22, 2020: Prospectus

November 20, 2020: Business Combination

Update(s)

On May 20, 2020, the Registration Statement on Form S-1 relating to the initial public offering  of Longview Acquisition Corp. was declared effective by the U.S. Securities and Exchange Commission. On May 26, 2020, the Company consummated the IPO of 36,000,000 units.

November 20, 2020: Butterfly Network, an innovative digital health company that is working to enable universal access to superior medical imaging, and Longview Acquisition Corp. (LGVW), a special purpose acquisition company sponsored by Glenview Capital Management, LLC, announced that they have entered into a definitive business combination agreement. Upon closing, the combined company’s Class A common stock is expected to be traded on the New York Stock Exchange under the symbol “BFLY.”

February 12, 2021: Longview Acquisition (LGVW) announced that its stockholders voted to approve the proposed business combination with Butterfly Network, Inc.

February 16, 2021: Butterfly Network (BFLY) announced that it has completed its business combination with Longview Acquisition (LGVW).

CarLotz, Inc. 10/22/2020 LOTZ

Business Combination details

Warrant Symbol: LOTZW, Warrant Price: $2.20

January 08, 2019: Registration

February 22, 2019: Initial Public Offering

February 22, 2019: Prospectus

October 22, 2020: Business Combination

Update(s)

February 22, 2019: Acamar Partners Acquisition priced its initial public offering of 30,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market and trade under the ticker symbol “ACAMU” beginning February 22, 2019. Each unit consists of one share of the Company’s Class A common stock and one-third of one redeemable warrant, each whole warrant enabling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “ACAM” and “ACAMW,” respectively.

October 22, 2020: Acamar Partners Acquisition (ACAM) and CarLotz, Inc., one of the largest privately-held used vehicle retail disruptors with the industry’s only consignment-to-retail sales platform, announced today they executed a definitive business combination agreement that would make CarLotz a public company. At closing, anticipated in the fourth quarter of 2020, the combined company will be named CarLotz, Inc. and is expected to remain listed on Nasdaq and trade under the new ticker symbol LOTZ.

January 21, 2021: CarLotz (LOTZ) announced that it has completed its business combination with Acamar Partners Acquisition (ACAM). The Business Combination was approved on January 20, 2021 by Acamar Partners’ stockholders. Beginning January 22, 2021, CarLotz’ shares will trade on the Nasdaq Global Market under the ticker symbol “LOTZ.”

GeminiTherapeutics 10/15/2020 GMTX

Business Combination details

July 24, 2020: Registration

August 12, 2020: Initial Public Offering

August 13, 2020: Prospectus

October 15, 2020: Business Combination

Update(s)

August 12, 2020 – FS Development Corp. (FSDC) announced today that it priced its initial public offering of 10,500,000 shares of Class A common stock at $10.00 per share. The shares will be listed on The Nasdaq Capital Market and trade under the ticker symbol “FSDC” beginning August 12, 2020. The Company expects the offering to be consummated on August 14, 2020.

October 15, 2020: Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), and FS Development Corp. (FSDC) announced they have entered into a definitive merger agreement. Upon closing of the transaction, the company will be renamed “Gemini Therapeutics, Inc.” and will be led by Jason Meyenburg, Chief Executive Officer of Gemini. The Combined Company’s common stock is expected to be listed on Nasdaq.

February 3, 2021: Shareholders of FS Development (FSDC) approved its combination with biotech firm Gemini Therapeutics.

February 8, 2021: Gemini Therapeutics announced the completion of its business combination with FS Development (FSDC). Gemini Therapeutics, Inc., the resulting combined company, will commence trading its shares today on the Nasdaq Global Market under the symbol “GMTX.”

E2open 10/14/2020 ETWO

Business Combination details

Unit Symbol: PCPL-UN, Unit Price: $11.63

Warrant Symbol: PCPL-WT, Warrant Price: $2.48

March 06, 2020: Registration

April 24, 2020: Initial Public Offering

April 27, 2020: Prospectus

October 14, 2020: Business Combination

Update(s)

April 24, 2020: The Registration Statement on Form S-1 relating to the initial public offering of CC Neuberger Principal Holdings I was declared effective by the U.S. Securities and Exchange Commission.

October 14, 2020: E2open, a leading network-based provider of 100% cloud-based, end-to-end supply chain management software, today announced it has entered into a business combination agreement with CC Neuberger Principal Holdings I (PCPL), a publicly traded special purpose acquisition company. Upon closing of the transaction, E2open will become a publicly traded company, and it is expected that its common stock will be listed on the New York Stock Exchange under the symbol “ETWO”. Michael Farlekas, who has served as CEO of the Company since 2015, will continue to lead the business post-transaction.

February 2, 2021: CC Neuberger Principal Holdings I (PCPL) announced that its shareholders approved its combination with supply chain software provider E2Open.

February 5, 2021: E2open and CC Neuberger Principal Holdings I (PCPL) announced that they have completed their business combination. The common stock of the combined company will trade under the symbol "ETWO" on the New York Stock Exchange, beginning February 5, 2021. 

Clover Health Investments, Corp. 10/06/2020 CLOV

Business Combination details

Warrant Symbol: CLOVW, Warrant Price: $1.78

February 28, 2020: Registration

April 22, 2020: Initial Public Offering

April 23, 2020: Prospectus

October 06, 2020: Business Combination

Update(s)

pril 21, 2020: Social Capital Hedosophia Holdings Corp. III priced its initial public offering of 72,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange and trade under the ticker symbol "IPOC.U" beginning April 22, 2020. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the NYSE under the symbols "IPOC" and "IPOC WS," respectively.
October 6, 2020: Clover Health Investments, which operates next-generation Medicare Advantage plans, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Hedosophia Holdings Corp. III.
January 6, 2021: Social Capital Hedosophia Holdings Corp. III, announced that in an extraordinary general meeting on January 6, 2021, its shareholders voted to approve its proposed business combination with Clover Health Investments, Corp. The business combination is expected to close on January 7, 2021. Trading is expected to begin on The Nasdaq Global Select Market on January 8, 2021, under the new ticker symbol “CLOV” for Clover Health Class A common stock and “CLOVW” for Clover Health warrants.
January 7, 2021: Clover Health Investments, an innovative technology company improving health outcomes for America’s seniors, and Social Capital Hedosophia Holdings (IPOC)  completed their previously announced business combination to form one of the nation’s fastest growing publicly-traded Medicare Advantage insurers. The newly formed company is named Clover Health Investments, Corp. and its shares of Class A common stock and warrants will start trading on The Nasdaq Global Select Market under the new ticker symbols “CLOV” and “CLOVW,” respectively.

April 21, 2020: Social Capital Hedosophia Holdings Corp. III priced its initial public offering of 72,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange and trade under the ticker symbol "IPOC.U" beginning April 22, 2020. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the NYSE under the symbols "IPOC" and "IPOC WS," respectively.

October 6, 2020: Clover Health Investments, which operates next-generation Medicare Advantage plans, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Hedosophia Holdings Corp. III.

January 6, 2021: Social Capital Hedosophia Holdings Corp. III, announced that in an extraordinary general meeting on January 6, 2021, its shareholders voted to approve its proposed business combination with Clover Health Investments, Corp. The business combination is expected to close on January 7, 2021. Trading is expected to begin on The Nasdaq Global Select Market on January 8, 2021, under the new ticker symbol “CLOV” for Clover Health Class A common stock and “CLOVW” for Clover Health warrants.

January 7, 2021: Clover Health Investments, an innovative technology company improving health outcomes for America’s seniors, and Social Capital Hedosophia Holdings (IPOC)  completed their previously announced business combination to form one of the nation’s fastest growing publicly-traded Medicare Advantage insurers. The newly formed company is named Clover Health Investments, Corp. and its shares of Class A common stock and warrants will start trading on The Nasdaq Global Select Market under the new ticker symbols “CLOV” and “CLOVW,” respectively.

Danimer Scientific 10/05/2020 DNMR

Business Combination details

Warrant Symbol: DNMR-WT, Warrant Price: $21.04

March 02, 2020: Registration

May 06, 2020: Initial Public Offering

May 06, 2020: Prospectus

October 05, 2020: Business Combination

Update(s)

May 6, 2020: Live Oak Acquisition Corp priced its initial public offering of 20,000,000 units at $10.00 per unit. While the Company may pursue an initial business combination target in any business or industry, it intends to focus its search on companies in the financial services, industrial, business services, and real estate sectors. The units will be listed on the New York Stock Exchange and will begin trading tomorrow, Wednesday, May 6, 2020, under the ticker symbol “LOAK.U” Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on the NYSE under the symbols “LOAK” and “LOAK WS,” respectively.

October 5, 2020: Danimer Scientific, a next generation bioplastics company focused on the development and production of biodegradable materials, and Live Oak Acquisition (LOAK) announced a definitive agreement for a business combination that would result in Danimer Scientific becoming a public company. Upon closing of the transaction, the combined company will be renamed Danimer Scientific and is expected to remain listed on the NYSE under a new ticker symbol. Danimer will continue to be led by Stephen E. Croskrey, Danimer’s current Chief Executive Officer.

December 29, 2020: Meredian Holdings Group doing business as Danimer Scientific, a next generation bioplastics company focused on the development and production of biodegradable materials, and Danimer Scientific announced that they have completed their previously announced business combination. In connection with the closing, Live Oak changed its name to Danimer Scientific. The common stock of Danimer Scientific will trade under the ticker symbol “DNMR” on the New York Stock Exchange beginning December 30, 2020.

Playboy 10/01/2020 PLBY

Business Combination details

Unit Symbol: MCACU, Unit Price: $15.95

Warrant Symbol: MCACR, Warrant Price: $1.30

November 10, 2020: Registration

June 05, 2020: Initial Public Offering

June 05, 2020: Prospectus

October 01, 2020: Business Combination

Update(s)

June 4, 2020: Mountain Crest Acquisition Corp priced its initial public offering of 5,000,000 units at $10.00 per unit. The units are expected to be listed on The NASDAQ Capital Market and trade under the ticker symbol "MCACU" beginning tomorrow, June 5, 2020. Each unit consists of one share of common stock and one right to receive one-tenth of one share of common stock upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the common stock and rights are expected to be listed on NASDAQ under the symbols "MCAC," and "MCACR," respectively.

October 1, 2020: Playboy Enterprises, Inc. and Mountain Crest Acquisition Corp. (MCAC) announced the signing of a definitive merger agreement to return Playboy to the public markets. In addition, they announced the signing of definitive purchase agreements with institutional and accredited investors for the purchase of $50 million of common stock at $10 per share. Upon closing of the transaction, Mountain Crest will be renamed and is expected to remain listed on the Nasdaq Stock Market under ticker PLBY.

February 9, 2021: Mountain Crest Acquisition (MCAC) announced that in a special meeting of stockholders, its stockholders voted to approve its proposed business combination with Playboy Enterprises, Inc. The business combination is expected to close on February 10, 2021, subject to the satisfaction of certain customary closing conditions. As part of the consummation of the business combination, Mountain Crest will change its name to “PLBY Group, Inc.” Trading on The Nasdaq Global Market, under the new ticker symbol “PLBY,” is expected to begin on February 11, 2021.Playboy Enterprises, Inc. and Mountain Crest Acquisition Corp. (MCAC) announced the signing of a definitive merger agreement to return Playboy to the public markets. In addition, they announced the signing of definitive purchase agreements with institutional and accredited investors for the purchase of $50 million of common stock at $10 per share. Upon closing of the transaction, Mountain Crest will be renamed and is expected to remain listed on the Nasdaq Stock Market under ticker PLBY.

February 10, 2021: Playboy Enterprises (PLBY) and Mountain Crest Acquisition Corp (MCAC) announced the completion of their business combination.

Nuvation Bio 10/01/2020 NUVB

Business Combination details

Unit Symbol: PANA-UN, Unit Price: $11.47

Warrant Symbol: NUVB-WT, Warrant Price: $2.60

June 12, 2020: Registration

July 01, 2020: Initial Public Offering

July 02, 2020: Prospectus

October 01, 2020: Business Combination

Update(s)

June 30, 2020 — Panacea Acquisition Corp. (PANA), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The Company is sponsored by EcoR1 Panacea Holdings, LLC, an affiliate of EcoR1 Capital, LLC. While the Company may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business operating in the biotechnology sector.

October 21, 2020: Nuvation Bio Inc., a biopharmaceutical company focused on revolutionizing cancer treatment by discovering, developing and delivering therapies that tackle some of the greatest needs in oncology, and Panacea Acquisition Corp. (PANA), a special purpose acquisition company (SPAC) sponsored by EcoR1 Capital, today announced they have entered into a definitive business combination agreement. Upon closing of the transaction, Panacea will be renamed Nuvation Bio Inc.; its common stock is expected to remain listed on the New York Stock Exchange under the new ticker symbol "NUVB."

February 9, 2021: Panacea Acquisition Corporation (PANA) announced that its shareholders have approved its combination with drug developer Nuvation Bio at a special meeting.

February 10, 2021: Nuvation Bio and Panacea Acquisition Corporation (PANA) consummated the transactions contemplated by the Agreement and Plan of Merger among them.

Only premium members can access the SPAC Business Combination. Subscribe today.